# FDA Inspection 1226933 - Hospira Zagreb d.o.o. - December 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/hospira-zagreb-doo/5ed2d30f-de41-4bc1-a591-84b6ec581216
Source feed: FDA_Inspections

> FDA Inspection 1226933 for Hospira Zagreb d.o.o. on December 16, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226933
- Company Name: Hospira Zagreb d.o.o.
- Inspection Date: 2021-12-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1225278 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/hospira-zagreb-doo/44865511-9c08-4b4a-bf39-0fe676c1561a)
- [FDA Inspection 1123692 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/hospira-zagreb-doo/53387c32-9209-49d8-9c4d-defc024a571e)
- [FDA Inspection 1051780 - 2018-02-20](https://www.keypedia.com/records/fda_inspections/hospira-zagreb-doo/dad8f345-4f2f-46ea-9de9-fe6cb5716d0f)

Company: https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c